Experiences of Migraine and Erenumab Treatment in Japan: Qualitative Interviews with Clinical Trial Participants.

Dias-Barbosa C, Igarashi H, Duenas A, Hareendran A, Kitamura S, Tanaka S, Sanno N, Doi H, Nagamitsu T, Tatsuoka Y, Matsumori Y, Hasebe M, Takeshima T

Open source

DOI: 10.1007/s40271-026-00813-6
Published: 2026 Sep
Container: The patient
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s40271-026-00813-6,
  title = {Experiences of Migraine and Erenumab Treatment in Japan: Qualitative Interviews with Clinical Trial Participants.},
  author = {Dias-Barbosa C and Igarashi H and Duenas A and Hareendran A and Kitamura S and Tanaka S and Sanno N and Doi H and Nagamitsu T and Tatsuoka Y and Matsumori Y and Hasebe M and Takeshima T},
  year = {2026},
  journal = {The patient},
  doi = {10.1007/s40271-026-00813-6},
  url = {https://doi.org/10.1007/s40271-026-00813-6}
}

RIS

TY  - JOUR
TI  - Experiences of Migraine and Erenumab Treatment in Japan: Qualitative Interviews with Clinical Trial Participants.
AU  - Dias-Barbosa C
AU  - Igarashi H
AU  - Duenas A
AU  - Hareendran A
AU  - Kitamura S
AU  - Tanaka S
AU  - Sanno N
AU  - Doi H
AU  - Nagamitsu T
AU  - Tatsuoka Y
AU  - Matsumori Y
AU  - Hasebe M
AU  - Takeshima T
PY  - 2026
JO  - The patient
DO  - 10.1007/s40271-026-00813-6
UR  - https://doi.org/10.1007/s40271-026-00813-6
ER  -

APA

C, D., H, I., A, D., A, H., S, K., S, T., N, S., H, D., T, N., Y, T., Y, M., M, H., & T, T. (2026). Experiences of Migraine and Erenumab Treatment in Japan: Qualitative Interviews with Clinical Trial Participants.. The patient. https://doi.org/10.1007/s40271-026-00813-6

Source records

pubmed · retrieved 2026-09-25T10:25:41.705Z